Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RSBMJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Sofituzumab vedotin
|
|||||
| Synonyms |
Anti-MUC16 ADC MMAE; Anti-MUC16 MMAE ADC; Anti-MUC16 mAb MMAE; Anti-MUC16 monoclonal antibody MMAE; Anti-MUC16 monoclonal antibody monomethyl auristatin E conjugate; Anti-MUC16 monoclonal antibody vedotin; DMUC-5754A; DMUC5754A; MMAE anti-MUC16; MMAE anti-MUC16 mAb; RG-7458; RG7458, DMUC 5754A; Sofituzumab vedotin
Click to Show/Hide
|
|||||
| Organization |
Genentech, Inc.; Roche Holding AG
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 2 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
3 to 4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Anti-MUC16 Anti-ody 3A5
|
Antibody Info | ||||
| Antigen Name |
Mucin-16 (MUC16)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
| Combination Type |
vedotin
|
|||||
| Puchem SID | ||||||
| Drugbank ID | ||||||
| ChEBI ID | ||||||
